62 related articles for article (PubMed ID: 33438101)
1. Prognostic Significance of Neutrophil to Lymphocyte Ratio Dynamics in Patients with Hepatocellular Carcinoma Treated with Radioembolization Using Glass Microspheres.
Li X; Montazeri SA; Paz-Fumagalli R; Padula CA; Wang W; Mody K; Roberts LR; Patel T; Krishnan S; Toskich B
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2624-2634. PubMed ID: 33438101
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of neutrophil-to-lymphocyte ratio change in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy.
Yin X; Chen H; Sun Y; Xiao L; Lu H; Guo W; Yang H; Zhou J; Fan K; Liang W
Sci Rep; 2024 May; 14(1):11984. PubMed ID: 38796631
[TBL] [Abstract][Full Text] [Related]
3. High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
Rich NE; Parvathaneni A; Sen A; Odewole M; Arroyo A; Mufti AR; Kerr TA; Grant L; Tujios SR; Mayo MJ; Lee WM; Yang JD; Yokoo T; Gopal P; Hoshida Y; Zhu H; Yopp AC; Marrero JA; Singal AG
Dig Dis Sci; 2022 Jun; 67(6):2666-2676. PubMed ID: 33939138
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of neutrophil-to-lymphocyte ratio dynamics in patients with septic acute kidney injury: a cohort study.
Wei W; Liu C; Song G; Yang L; Li J; Wang B; Yin T; Yang Y; Ma L; Zhang L; Fu P; Zhao Y
Ren Fail; 2024 Dec; 46(1):2343818. PubMed ID: 38637281
[TBL] [Abstract][Full Text] [Related]
5. Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy.
Reddy AV; Hill CS; Sehgal S; Zheng L; He J; Laheru DA; Jesus-Acosta A; Herman JM; Meyer J; Narang AK
Radiat Oncol J; 2022 Jun; 40(2):111-119. PubMed ID: 35796114
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab.
Xiao Y; Zhu G; Xie J; Luo L; Deng W; Lin L; Tao J; Hu Z; Shan R
J Hepatocell Carcinoma; 2023; 10():2049-2058. PubMed ID: 37965074
[TBL] [Abstract][Full Text] [Related]
7. Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere.
Kim GM; Kim DY; Won JY; Moon S; Kim SU; Kim BK
Cardiovasc Intervent Radiol; 2024 May; ():. PubMed ID: 38744685
[TBL] [Abstract][Full Text] [Related]
8. Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience.
Palčić Marija G; Hana M; Ivan K; Lucija V; Vedran H; Luka V; Mrsić F; Radovan Z; Ivana Ć; Petar G
Biochem Med (Zagreb); 2023 Jun; 33(2):020704. PubMed ID: 37324114
[TBL] [Abstract][Full Text] [Related]
9. Significance of neutrophil to lymphocyte ratio as a predictor of outcome in head and neck cancer treated with definitive chemoradiation.
Kaźmierska J; Bajon T; Winiecki T; Borowczak D; Bandurska-Luque A; Jankowska M; Żmijewska-Tomczak M
Rep Pract Oncol Radiother; 2023; 28(3):389-398. PubMed ID: 37795402
[TBL] [Abstract][Full Text] [Related]
10. Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol.
Andel D; Lam MGEH; de Bruijne J; Smits MLJ; Braat AJAT; Moelker A; Vegt E; Ruiter SJS; Noordzij W; Grazi G; Vallati GE; Bennink RJ; van Delden OM; Kranenburg OW; Ijzermans JNM; Nijkamp MW; Erdmann JI; Sciuto R; Hagendoorn J; Borel Rinkes IHM
BMC Cancer; 2023 Aug; 23(1):771. PubMed ID: 37596578
[TBL] [Abstract][Full Text] [Related]
11. Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study.
Nam H; Yang H; Chun HS; Lee HA; Nam JY; Jang JW; Seo YS; Kim DY; Kim YJ; Bae SH
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958368
[TBL] [Abstract][Full Text] [Related]
12. Serum inflammatory markers as prognostic marker for nasopharyngeal carcinoma with liver metastasis: a multi-center retrospective study.
Saboorifar H; Zafarani Y; Gholampour G; Roghani A; Qiu F; Dequaniter D; Yu Q
Eur Arch Otorhinolaryngol; 2024 Apr; ():. PubMed ID: 38642085
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib.
Yuan J; Liang H; Li J; Li M; Tang B; Ma H; Xie X; Yin X; Zhang L; Ren Z
Mol Clin Oncol; 2017 Nov; 7(5):837-842. PubMed ID: 29181175
[TBL] [Abstract][Full Text] [Related]
14. Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics.
Da Fonseca LG; Yamamoto VJ; Trinconi Cunha M; Torre GS; Araujo RLC; Fonseca GM; Chen ATC; Chagas AL; Herman P; Alves VAF; Carrilho FJ
J Hepatocell Carcinoma; 2023; 10():1923-1933. PubMed ID: 37933267
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature.
Braat MNGJA; Ebbers SC; Alsultan AA; Neek AO; Bruijnen RCG; Smits MLJ; de Bruijne J; Lam MGEH; Braat AJAT
Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132236
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Liver Transplantation after 90Y Radioembolization: Lessons from a Radiation Protection Incident.
Soret M; Maisonobe JA; Maksud P; Payen S; Allaire M; Savier E; Roux C; Lussey-Lepoutre C; Kas A
Health Phys; 2024 Mar; ():. PubMed ID: 38535982
[TBL] [Abstract][Full Text] [Related]
17. Exploring predictive markers for liver failure post-hepatectomy in hepatocellular carcinoma patients.
Zhang SY; Ma XJ; Zhu XX; Cai N
World J Gastrointest Surg; 2024 May; 16(5):1482-1484. PubMed ID: 38817295
[TBL] [Abstract][Full Text] [Related]
18. Pathologic Response of Hepatocellular Carcinoma Treated with Yttrium-90 Glass Microsphere Radiation Segmentectomy Prior to Liver Transplantation: A Validation Study.
Toskich B; Vidal LL; Olson MT; Lewis JT; LeGout JD; Sella DM; Montazeri SA; Devcic Z; Lewis AR; Frey GT; Ritchie CA; Paz-Fumagalli R; Croome KP; Patel TC
J Vasc Interv Radiol; 2021 Apr; 32(4):518-526.e1. PubMed ID: 33551304
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous direct pancreatic duct intervention in management of pancreatic fistulas: a primary treatment or temporizing therapy to prepare for elective surgery.
Li X; Paz-Fumagalli R; Wang W; Toskich BB; Stauffer JA; Frey GT; McKinney JM; Nguyen JH
BMC Gastroenterol; 2021 Jan; 21(1):44. PubMed ID: 33509111
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Radiation Lobectomy and Immunotherapy for Angioinvasive HCC Resulting in Complete Pathologic Response.
Liou H; Mody K; Boyle AW; Keaveny AP; Croome KP; Burns JM; Harnois DM; Patel TC; Toskich B
Hepatology; 2021 Jul; 74(1):525-527. PubMed ID: 33615518
[No Abstract] [Full Text] [Related]
[Next] [New Search]
